FILE:AGN/AGN-8K-20040709131625.txt.gz
EVENTS:	Other events	Financial statements and exhibits
TEXT:
ITEM: Other events
ITEM: Financial statements and exhibits
 
 
Item 5. Other Events.
     Ronald M. Cresswell has retired as a director of Allergan, effective July 9, 2004. There were no disagreements with Allergan on any matter relating to Allergan's operations, policies or practices.
     The full text of the press release relating to Professor Cresswell's retirement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by this reference.
Item 7. Exhibits.
     99.1 Press Release dated July 9, 2004.
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
               
Exhibit No.
Description
     99.1                Press Release dated July 9, 2004.

 
Exhibit 99.1
 Allergan, Inc. (NYSE: AGN) today announced that, for personal health reasons, Ronald M. Cresswell has retired as a director of Allergan, effective July 9, 2004.
IRVINE, Calif.
, July 9, 2004
"Since joining Allergan's Board of Directors in 1998, Professor Cresswell has been an invaluable and insightful director, blessing Allergan's Board with his excellent judgment, healthcare industry knowledge, and pharmaceutical research and development expertise," said David E.I. Pyott, Allergan's Chairman of the Board, President and CEO. "Professor Cresswell will be deeply missed by Allergan's Board, and I am grateful for his service."
About Allergan, Inc.
Allergan, Inc., with headquarters in Irvine, California, is a technology-driven, global health care company providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care, neuromodulator, skin care and other specialty markets that deliver value to its customers, satisfy unmet medical needs, and improve patients' lives.
Jim Hindman (714) 246-4636 (Investors) Stephanie Fagan (714) 246-5232 (Media) Caroline Van Hove (714) 246-5134 (Media)
Allergan Contacts:


